Publications by authors named "Karla Vrkic"
Article Synopsis
- Biologic DMARDs are effective for rheumatic diseases but are costly and require careful management by doctors; this study explored their prescription changes during the COVID-19 pandemic at the University Hospital of Split.
- Data showed a 11.5% decrease in patients processed and a reduction in overall biologic prescriptions (from 231 to 204) during the pandemic, with notable changes in specific drug usage.
- Prescriptions of IL-6 inhibitors dropped significantly, while IL-17A inhibitors increased; overall, the prescription trends remained mostly stable despite the challenges posed by the pandemic.
